December 31, December 31, $ %
2007 2006
Revenue
United States $451 $952 $(501) (53)%
Europe 134 423 (289) (68)%
Western Hemisphere
(excluding U.S.) 1,631 4,089 (2,458) (60)%
Pacific Rim 816 428 388 91%
Total Revenue $3,032 $5,892 $(2,860) (49)%
Contact: Charles R. Trego, Jr., Chief Financial Officer
(716) 855-1068
About the Company
MINRAD International, Inc. is an interventional pain management company with real-time image guidance, anesthesia and analgesia, conscious sedation product lines. The real-time image guidance products facilitate minimally invasive surgery especially for pain management and have broad applications in orthopedics, neurosurgery, and interventional radiology. These devices enable medical professionals to improve the accuracy of interventional procedures and reduce radiation exposure. MINRAD International also manufactures and markets generic inhalation anesthetics for use in connection with human and veterinary surgical procedures. The company is developing a drug/drug delivery system for conscious sedation, which, similar to nitrous oxide in dental surgery, provides a patient with pain relief without loss of consciousness. Additional information can be found at the company's website, http://www.minrad.com.
The information contained in this news release, other than historical
information, consists of forward-looking statements within the meaning of
the Private Securities Litigat
'/>"/>
| SOURCE MINRAD International, Inc. Copyright©2008 PR Newswire. All rights reserved |